{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:48:18Z","timestamp":1780073298358,"version":"3.54.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>Disorders of the long arm of chromosome 11 (11q) are rare and involve various chromosomal regions. Patients with 11q disorders, including Jacobsen syndrome, often present with a susceptibility for bacterial and prolonged viral and fungal infections partially explained by hypogammaglobulinemia. Additional T lymphocyte or granular neutrophil dysfunction may also be present. In order to evaluate infectious burden and immunological function in patients with 11q disorders, we studied a cohort of 14 patients with 11q deletions and duplications. Clinically, 12 patients exhibited prolonged and repetitive respiratory tract infections, frequently requiring (prophylactic) antibiotic treatment (<jats:italic>n<\/jats:italic>\u2009=\u20097), ear-tube placement (<jats:italic>n<\/jats:italic>\u2009=\u20099), or use of inhalers (<jats:italic>n<\/jats:italic>\u2009=\u20095). Complicated varicella infections (<jats:italic>n<\/jats:italic>\u2009=\u20095), chronic eczema (<jats:italic>n<\/jats:italic>\u2009=\u20096), warts (<jats:italic>n<\/jats:italic> = 2), and chronic fungal infections (<jats:italic>n<\/jats:italic>\u2009=\u20094) were reported. Six patients were on immunoglobulin replacement therapy. We observed a high prevalence of low B lymphocyte counts (<jats:italic>n<\/jats:italic>\u2009=\u20098), decreased T lymphocyte counts (<jats:italic>n<\/jats:italic>\u2009=\u20095) and abnormal T lymphocyte function (<jats:italic>n<\/jats:italic>\u2009=\u200912). Granulocyte function was abnormal in 29% without a clinical phenotype. Immunodeficiency was found in patients with terminal and interstitial 11q deletions and in one patient with terminal 11q duplication. Genetically, <jats:italic>FLI1<\/jats:italic> and <jats:italic>ETS1<\/jats:italic> are seen as causative for the immunodeficiency, but these genes were deleted nor duplicated in 4 of our 14 patients. Alternative candidate genes on 11q may have a role in immune dysregulation. In conclusion, we present evidence that inborn errors of immunity are present in patients with 11q disorders leading to clinically relevant infections. Therefore, broad immunological screening and necessary treatment is of importance in this patient group.\n<\/jats:p>","DOI":"10.1007\/s10875-022-01303-8","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T10:16:52Z","timestamp":1656411412000},"page":"1521-1534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Patients with Chromosome 11q Deletions Are Characterized by Inborn Errors of Immunity Involving both B and T Lymphocytes"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0700-2194","authenticated-orcid":false,"given":"Elise J.","family":"Huisman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rick","family":"Brooimans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samone","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4443-4690","authenticated-orcid":false,"given":"Marieke","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3099-4475","authenticated-orcid":false,"given":"Louis","family":"de Bont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00eblle","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth L. M.","family":"Rammeloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8131-3521","authenticated-orcid":false,"given":"Frans J.","family":"Smiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Martin","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1353-9166","authenticated-orcid":false,"given":"C. Michel","family":"Zwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7044-0525","authenticated-orcid":false,"given":"Masja","family":"de Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-2995","authenticated-orcid":false,"given":"Marjon H.","family":"Cnossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5945-4435","authenticated-orcid":false,"given":"Virgil A. S. H.","family":"Dalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"issue":"1","key":"1303_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ajmg.a.30090","volume":"129A","author":"PD Grossfeld","year":"2004","unstructured":"Grossfeld PD, et al. The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet A. 2004;129A(1):51\u201361.","journal-title":"Am J Med Genet A"},{"issue":"12","key":"1303_CR2","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/ajmg.a.34300","volume":"155A","author":"A Hagen","year":"2011","unstructured":"Hagen A, et al. Combined partial trisomy 11q and partial monosomy 10p in a 19-year-old female patient: phenotypic and genotypic findings. Am J Med Genet A. 2011;155A(12):3075\u201381.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"1303_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1046\/j.1440-1754.2001.00587.x","volume":"37","author":"K Maruyama","year":"2001","unstructured":"Maruyama K, Koizumi T, Ikeda H. Partial monosomy 10q with partial trisomy 11q due to paternal balanced translocation. J Paediatr Child Health. 2001;37(2):198\u2013200.","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"1303_CR4","first-page":"676","volume":"56","author":"LA Penny","year":"1995","unstructured":"Penny LA, et al. Clinical and molecular characterization of patients with distal 11q deletions. Am J Hum Genet. 1995;56(3):676\u201383.","journal-title":"Am J Hum Genet"},{"key":"1303_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13039-016-0247-7","volume":"9","author":"J Su","year":"2016","unstructured":"Su J, et al. de novo interstitial deletions at the 11q23.3\u2013q24.2 region. Mol Cytogenet. 2016;9:39.","journal-title":"Mol Cytogenet"},{"issue":"8","key":"1303_CR6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10875-015-0211-z","volume":"35","author":"VA Dalm","year":"2015","unstructured":"Dalm VA, et al. The 11q Terminal Deletion Disorder Jacobsen Syndrome is a syndromic primary immunodeficiency. J Clin Immunol. 2015;35(8):761\u20138.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1303_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s10875-013-9966-2","volume":"34","author":"M Sepp\u00e4nen","year":"2013","unstructured":"Sepp\u00e4nen M, et al. Terminal deletion of 11q with significant late-onset combined immune deficiency. J Clin Immunol. 2013;34(1):114\u20138.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1303_CR8","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.1016\/S0091-6749(03)80812-6","volume":"111","author":"CDE Miller","year":"2003","unstructured":"Miller CDE, Atkinson AR, Roifman CM. Immunodeficiency in Jacobsen syndrome. J Allergy Clin Immunol. 2003;111(2):S232.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1303_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1081-1206(10)60192-5","volume":"103","author":"G Puglisi","year":"2009","unstructured":"Puglisi G, et al. 11q terminal deletion disorder and common variable immunodeficiency. Ann Allergy Asthma Immunol. 2009;103(3):267\u20138.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"1303_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","volume":"31","author":"I Quinti","year":"2011","unstructured":"Quinti I, et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol. 2011;31(3):315\u201322.","journal-title":"J Clin Immunol"},{"issue":"12","key":"1303_CR11","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/ajmg.a.37859","volume":"170","author":"S Blazina","year":"2016","unstructured":"Blazina S, et al. 11q terminal deletion and combined immunodeficiency (Jacobsen syndrome): case report and literature review on immunodeficiency in Jacobsen syndrome. Am J Med Genet A. 2016;170(12):3237\u201340.","journal-title":"Am J Med Genet A"},{"key":"1303_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-1172-4-9","volume":"4","author":"T Mattina","year":"2009","unstructured":"Mattina T, Perrotta CS, Grossfeld P. Jacobsen syndrome. Orphanet J Rare Dis. 2009;4:9.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"1303_CR13","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1182\/blood.V85.7.1805.bloodjournal8571805","volume":"85","author":"J Breton-Gorius","year":"1995","unstructured":"Breton-Gorius J, et al. A new congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23 [see comments]. Blood. 1995;85(7):1805\u201314.","journal-title":"Blood"},{"issue":"2","key":"1303_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3324\/haematol.2009.012286","volume":"95","author":"M Wenham","year":"2010","unstructured":"Wenham M, et al. Two patients with Hermansky Pudlak syndrome type 2 and novel mutations in AP3B1. Haematologica. 2010;95(2):333\u20137.","journal-title":"Haematologica"},{"issue":"2","key":"1303_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1182\/bloodadvances.2020002442","volume":"5","author":"CEM Aarts","year":"2021","unstructured":"Aarts CEM, et al. Neutrophil specific granule and NETosis defects in gray platelet syndrome. Blood Adv. 2021;5(2):549\u201364.","journal-title":"Blood Adv"},{"issue":"6550","key":"1303_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/377635a0","volume":"377","author":"JC Bories","year":"1995","unstructured":"Bories JC, Willerford DM, Gr\u00e9vin D, Davidson L, Camus A, Marti P, et al. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature. 1995;377(6550):635\u20138.","journal-title":"Nature"},{"key":"1303_CR17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/377639a0","volume":"377","author":"N Muthusamy","year":"1995","unstructured":"Muthusamy N, Barton K, Leiden JM. Defective activation and survival of T cells lacking the ETS-1 transcription factor. Nature. 1995;377:639\u201342.","journal-title":"Nature"},{"issue":"3","key":"1303_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cyto.2010.03.006","volume":"51","author":"L Russell","year":"2010","unstructured":"Russell L, Garrett-Sinha LA. Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine. 2010;51(3):217\u201326.","journal-title":"Cytokine"},{"issue":"18","key":"1303_CR19","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1007\/s00018-012-1243-7","volume":"70","author":"LA Garret-Sinha","year":"2013","unstructured":"Garret-Sinha LA. Review of ETS1 structure, function, and roles in immunity. Cell Mol Life Sci. 2013;70(18):3375\u201390.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"1303_CR20","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","volume":"123","author":"I Salaverria","year":"2014","unstructured":"Salaverria I, et al. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood. 2014;123(8):1187\u201398.","journal-title":"Blood"},{"key":"1303_CR21","doi-asserted-by":"publisher","unstructured":"Tootleman E, et al. Partial Jacobsen syndrome phenotype in a patient with a de novo frameshift mutation in the ETS1 transcription factor. Cold Spring Harb Mol Case Stud. 2019. 5(3):a004010. https:\/\/doi.org\/10.1101\/mcs.a004010","DOI":"10.1101\/mcs.a004010"},{"issue":"3","key":"1303_CR22","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.4049\/jimmunol.181.3.1644","volume":"181","author":"XK Zhang","year":"2008","unstructured":"Zhang XK, et al. The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice. J Immunol. 2008;181(3):1644\u201354.","journal-title":"J Immunol"},{"issue":"6","key":"1303_CR23","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1128\/MCB.16.6.2708","volume":"16","author":"F Melet","year":"1996","unstructured":"Melet F, et al. Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia. Mol Cell Biol. 1996;16(6):2708\u201318.","journal-title":"Mol Cell Biol"},{"issue":"21","key":"1303_CR24","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1128\/MCB.01112-09","volume":"30","author":"O Moussa","year":"2010","unstructured":"Moussa O, et al. Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1. Mol Cell Biol. 2010;30(21):5194\u2013206.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"1303_CR25","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/ajmg.a.61113","volume":"179","author":"S Conrad","year":"2019","unstructured":"Conrad S, et al. 11q24.2q24.3 microdeletion in two families presenting features of Jacobsen syndrome, without intellectual disability: Role of FLI1, ETS1, and SENCR long noncoding RNA. Am J Med Genet A. 2019;179(6):993\u20131000.","journal-title":"Am J Med Genet A"},{"issue":"16","key":"1303_CR26","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1097\/CM9.0000000000000854","volume":"133","author":"K Li","year":"2020","unstructured":"Li K, et al. Age-dependent changes of total and differential white blood cell counts in children. Chin Med J (Engl). 2020;133(16):1900\u20137.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"1303_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/cyto.a.22520","volume":"87","author":"F Tosato","year":"2015","unstructured":"Tosato F, et al. Lymphocytes subsets reference values in childhood. Cytometry A. 2015;87(1):81\u20135.","journal-title":"Cytometry A"},{"issue":"4","key":"1303_CR28","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.4049\/jimmunol.0803548","volume":"183","author":"JJ Zaunders","year":"2009","unstructured":"Zaunders JJ, et al. High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40). J Immunol. 2009;183(4):2827\u201336.","journal-title":"J Immunol"},{"issue":"6","key":"1303_CR29","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.anai.2010.03.016","volume":"104","author":"DR Lotz","year":"2010","unstructured":"Lotz DR, Knutsen AP. Janus kinase 3 missense mutation in a child with jacobsen syndrome. Ann Allergy Asthma Immunol. 2010;104(6):536\u20137.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"1303_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/ajmg.10284","volume":"108","author":"K \u00d5unap","year":"2002","unstructured":"\u00d5unap K, et al. Girl with combined cellular immunodeficiency, pancytopenia, malformations, deletion 11q23.3 \u2192 qter, and trisomy 8q24.3 \u2192 qter. Am J Med Gen. 2002;108(4):322\u20136.","journal-title":"Am J Med Gen"},{"issue":"7","key":"1303_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1440-1754.2011.02136.x","volume":"47","author":"C Fern\u00e1ndez-San Jos\u00e9","year":"2011","unstructured":"Fern\u00e1ndez-San Jos\u00e9 C, et al. Hypogammaglobulinemia in a 12-year-old patient with Jacobsen syndromE. J Paediatr Child Health. 2011;47(7):485\u20136.","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"1303_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/jmg.39.1.57","volume":"39","author":"S Saviozzi","year":"2002","unstructured":"Saviozzi S, et al. A late onset variant of ataxia-telangiectasia with a compound heterozygous genotype, A8030G\/7481insA. J Med Genet. 2002;39(1):57\u201361.","journal-title":"J Med Genet"},{"issue":"3","key":"1303_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/humu.22016","volume":"33","author":"MM Verhagen","year":"2012","unstructured":"Verhagen MM, et al. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study. Hum Mutat. 2012;33(3):561\u201371.","journal-title":"Hum Mutat"},{"issue":"10","key":"1303_CR34","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1172\/JCI200422588","volume":"114","author":"G de Saint Basile","year":"2004","unstructured":"de Saint Basile G, et al. Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3. J Clin Invest. 2004;114(10):1512\u20137.","journal-title":"J Clin Invest"},{"key":"1303_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-065X.2008.00655.x","volume":"224","author":"F Huang","year":"2008","unstructured":"Huang F, Gu H. Negative regulation of lymphocyte development and function by the Cbl family of proteins. Immunol Rev. 2008;224:229\u201338.","journal-title":"Immunol Rev"},{"issue":"9","key":"1303_CR36","doi-asserted-by":"publisher","first-page":"R344","DOI":"10.1016\/S0960-9822(00)00463-2","volume":"10","author":"CE Rudd","year":"2000","unstructured":"Rudd CE, Schneider H. Lymphocyte signaling: Cbl sets the threshold for autoimmunity. Curr Biol. 2000;10(9):R344\u20137.","journal-title":"Curr Biol"},{"issue":"4","key":"1303_CR37","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/ajmg.a.36375","volume":"164A","author":"HL Hanson","year":"2014","unstructured":"Hanson HL, et al. Germline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23. Am J Med Genet A. 2014;164A(4):1003\u20139.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"1303_CR38","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1023\/A:1025594409056","volume":"8","author":"XZ Jiang","year":"2003","unstructured":"Jiang XZ, et al. Anti-IgM-induced down-regulation of nuclear Thy28 protein expression in Ramos B lymphoma cells. Apoptosis. 2003;8(5):509\u201319.","journal-title":"Apoptosis"},{"key":"1303_CR39","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/jhg.2010.51","volume":"55","author":"T Ji","year":"2010","unstructured":"Ji T, Wu Y, Wang H, et al. Diagnosis and fine mapping of a deletion in distal 11q in two Chinese patients with developmental delay. J Hum Genet. 2010;55:486\u20139.","journal-title":"J Hum Genet"},{"issue":"8","key":"1303_CR40","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/ajmg.a.32957","volume":"149A","author":"MT Carter","year":"2009","unstructured":"Carter MT, et al. Phenotypic delineation of Emanuel syndrome (supernumerary derivative 22 syndrome): Clinical features of 63 individuals. Am J Med Genet A. 2009;149A(8):1712\u201321.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"1303_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s10875-016-0286-1","volume":"36","author":"R Traynor","year":"2016","unstructured":"Traynor R, et al. Immunodeficiency in a child with 22q11.2 microduplication syndrome. J Clin Immunol. 2016;36(5):418\u20139.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1303_CR42","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/ajmg.a.35484","volume":"158A","author":"AH Bjork","year":"2012","unstructured":"Bjork AH, et al. Antibody deficiency in adults with 22q11.2 deletion syndrome. Am J Med Genet A. 2012;158A(8):1934\u201340.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"1303_CR43","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.4081\/pr.2010.e13","volume":"2","author":"G Colarusso","year":"2010","unstructured":"Colarusso G, et al. Evans syndrome and antibody deficiency: an atypical presentation of chromosome 22q11.2 deletion syndrome. Pediatr Rep. 2010;2(2):e13.","journal-title":"Pediatr Rep"},{"issue":"1","key":"1303_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/imr.12729","volume":"287","author":"JM Puck","year":"2019","unstructured":"Puck JM. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia. Immunol Rev. 2019;287(1):241\u201352.","journal-title":"Immunol Rev"},{"key":"1303_CR45","unstructured":"Dosanjh A. The use of TREC analysis as a newborn screening test for Jacobsen Syndrome and T cell deficiency. Int J Rare Dis Orphan Drugs. 2017;2(2):1007."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01303-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T21:43:05Z","timestamp":1668894185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01303-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1303"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01303-8","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"21 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval to conduct this study is given by IRB of the Erasmus Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients or caregivers consented.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors consented.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}